![](/images/buts/heroes_alert_button.jpg)
Lonza Group AG
SWF:LONN ISIN:CH0013841017
News
Global regenerative medicine company Mesoblast Limited (ASX:MSB) and Lonza Group (VTX:LONN), a world leader in biologic manufacturing, today announced that they have entered into a strategic alliance for clinical and long-term commercial production of Mesoblast's off-the-shelf (allogeneic) adult stem cell products.
###
2,775 COMPANY PROFILE VIEWS
- This Page Viewed: (Last 7 Days: 9) (Last 30 Days: 29) (Since Published: 2775)